Innate Pharma S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innate Pharma S.A. with three other
miscellaneous service companies in Europe:
sales of 49.74 million Euro [US$55.64 million]
of which 99%
was Partnered Discovery),
(51.01 million Euro [US$57.05 million]
of which 105%
was Therapeutics), and
Basilea Pharmaceutica Limited
based in Switzerland
(65.04 million Swiss Francs [US$66.64 million]
of which 100%
was Pharmaceutical Products).
Sales increased substantially in 2016:
Innate Pharma S.A. reported sales of 56.16 million Euro (US$62.82 million)
December of 2016.
increase of 213.6%
versus 2015, when the company's sales were 17.91 million Euro.